Company: ADPT
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030913
Chunk: 190

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-03-03
Form: 10-K
Item: Item 1B
Chunk 190
---
 restricted stock units and the maximum market-based restricted stock units forfeited or expired

        4,305,828

        Shares available for grant at December 31, 2024

        18,018,312

       Stock OptionsStock option activity under the 2009 Plan and 2019 Plan during the year ended December 31, 2024 was as follows:  

        Shares Subject toOutstanding Stock Options

        Weighted-Average ExercisePrice per Share

        Aggregate Intrinsic Value(in thousands)

        Stock options outstanding at December 31, 2023

        12,875,045

        $
        15.90

        Stock options granted

        1,008,364

        3.99

        Stock options forfeited

        (718,920
        )

        11.78

        Stock options expired

        (765,392
        )

        18.61

        Stock options exercised

        (103,800
        )

        2.32

        Stock options outstanding at December 31, 2024

        12,295,297

        $
        15.11

        $
        2,157

        Stock options vested and exercisable at December 31, 2024

        10,027,350

        $
        16.30

        $
        497

112

Adaptive Biotechnologies CorporationNotes to Consolidated Financial Statements (Continued) 

The weighted-average remaining contractual life for stock options outstanding as of December 31, 2024 was 5.4 years. The weighted-average remaining contractual life for vested and exercisable stock options as of December 31, 2024 was 4.9 years. The total intrinsic value of stock options exercised during the year ended December 31, 2024, 2023 and 2022 was $0.2 million, $1.4 million and $7.6 million, respectively.Restricted Stock UnitsRestricted stock unit activity under the 2019 Plan during the year ended December 31, 2024 was as follows: 

        Restricted Stock UnitsOutstanding

        Weighted-Average Grant DateFair Value per Share

        Nonvested restricted stock units outstanding at December 31, 2023

        9,669,460

        $
        10.32

        Restricted stock units granted

        5,619,008

        4.